Thursday, December 19, 2024
HomeTagsNanoGalaxy

NanoGalaxy

GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer

GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy platform for tissue-selective delivery, announced the appointment of J. Rodrigo Mora, M.D., Ph.D.,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics